(Q51060665)

27 March 2018

title

MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression. (English)

1 reference

27 March 2018

1 reference

Qianjun He

3

0 references

author name string

Limin Pan

series ordinal

1

1 reference

27 March 2018

Jianan Liu

series ordinal

2

1 reference

27 March 2018

Jianlin Shi

series ordinal

4

1 reference

27 March 2018

language of work or name

English

0 references

publication date

26 August 2014

1 reference

27 March 2018

published in

Advanced Materials

1 reference

27 March 2018

volume

26

1 reference

27 March 2018

issue

39

1 reference

27 March 2018

page(s)

6742-6748

1 reference

27 March 2018

Silica-based nanoprobes for biomedical imaging and theranostic applications.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Mesoporous silica nanoparticles in biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Functionalized mesoporous silica materials for controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

In vivo targeted delivery of nanoparticles for theranosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Nanoparticles that communicate in vivo to amplify tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Design considerations for tumour-targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Subcellular targeting strategies for drug design and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Synthetic cell surface receptors for delivery of therapeutics and probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Tumour vascular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Tumor delivery of macromolecular drugs based on the EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Peptide targeted lipid nanoparticles for anticancer drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Antibody-linked spherical nucleic acids for cellular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Progress and prospects: nuclear import of nonviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Targeted delivery to the nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Porous thin films of functionalized mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Synthesis of mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Virus-mimetic polymeric micelles for targeted siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Oral biodrug delivery using cell-penetrating peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201402752

21 January 2018

Identifiers

DOI

10.1002/ADMA.201402752

1 reference

27 March 2018

PubMed ID

25159109

1 reference

27 March 2018